The Chinese Market for Medical Polymers

  • June 2013
  • -
  • BCC Research
  • -
  • 145 pages

INTRODUCTION

This chapter provides an introduction to BCC’s report on the Chinese medical polymer market, describing study goals and objectives, reasons for doing the study, intended audience, scope, methodology, information sources, and analyst credentials.

STUDY GOALS AND OBJECTIVES

The goal of this study is to help readers form a comprehensive understanding of recent advances and trends in medical polymer consumption, manufacturing, applications, and technologies in China. Towards this end, the report will provide in-depth analysis of the Chinese medical polymers market.

The medical polymers include resins, fibers, elastomers, and other nonbiodegradable or biodegradable polymers used for medical purposes. In this report, the Chinese medical polymer market is divided into three segments: nonbiodegradable medical resins and fibers; nonbiodegradable medical elastomers; and biodegradable polymers.

Nonbiodegradable medical resins and fibers include polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), polystyrene (PS), polyacrylamide (PAM), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyacrylonitrile (PAN), polyamide (PA), polytetrafluoroethylene (PTFE), ethylene vinyl alcohol (EVA) copolymer, acrylic acid resins, polyethylene terephthalate (PET), cellulose, polyformaldehyde (POM), and polyethylene glycol (PEG) (see Appendix III for a glossary of abbreviations).
Nonbiodegradable medical elastomers include silicone rubber, polyurethane (PU), natural rubber latex (NRL), low-protein natural rubber latex (LPNRL), butyl rubber (BR), and thermoplastic elastomer (TPE).
Biodegradable medical polymers include polylactic acid (PLA), polycaprolactone (PCL), polycarbonate (PC), polyphosphate, polyhydroxyalkanoates (PHAS), polybutylene succinate (PBS), biodegradable PU, polypeptides, and biological rubber.

Four objectives in this report will be met. Major types of medical polymers and their future demand in the Chinese market will be described. Main technologies of medical polymers manufacturing will be discussed. Commercial applications in which medical polymers are used will be discussed. Finally, present consumption and future demand for medical polymers will be analyzed for the Chinese market by five regions: Yangtze River Delta, Pearl River Delta, North China, Middle China, and Other.

In addition, trends in technology will be analyzed. The impact of governmental regulations and international agreements will be ascertained. Patents relating to medical polymers will be discussed. The structural dynamics of the Chinese medical polymer industry will be outlined, along with profiles of key manufacturers in Shanghai, Beijing, Tianjin, Guangdong, Zhejiang, Jiangsu, Hubei, Liaoning, Fujian, Shandong, and other Chinese provinces and cities.

This report will review the Chinese market for medical polymers and will forecast trends and sales in these markets from 2011 through 2017. Important manufacturers, technologies, and factors influencing demand will be discussed.

The Chinese medical polymers market is closely related to the production and supplies of the pharmaceutical and medical device industries. Therefore, the current situation and trends of the medicines and medical devices market will be described as necessary.

BCC’s goal in conducting this study was to determine the current status of the medical polymer industry in China and to assess its growth potential over a five-year period from 2012 to 2017. A primary objective was to present a comprehensive analysis of the current Chinese medical polymer market and to project its future direction.

REASONS FOR DOING THE STUDY

There are three reasons for doing this study, as follows:

Polymer manufacturers need to understand the market trends and new technologies related to medical applications of their products in order to plan investment, production, and research and development for the next five or more years.
Pharmaceutical companies and medical device manufacturers need to understand the market and technology trends related to medical polymers to identify advanced raw materials.
Raw materials suppliers and manufacturers need to understand Chinese medical polymer market consumption and trends for planning production and research and development for the next five years.

SCOPE OF REPORT

The report forecasts the size of the Chinese market in current U.S. dollars for medical polymers in value terms and/or volume terms for each material from 2012 through 2017. The report forecasts the Chinese market size for medical polymers such as PE, PP, PS, PVC, and PU. The forecasts are classified on the basis of product type, application, and geographical region.

The report also describes the important players in the Chinese medical polymer industry. They include homegrown companies, foreign companies, and joint ventures.

INTENDED AUDIENCE

The intended audience for this report includes medical polymer manufacturers and suppliers. Pharmaceutical companies, medical device manufacturers, and petrochemicals suppliers may also be interested in this report.

METHODOLOGY

Estimates of current market demand are made for 2011 and are projected over the next five years. Projections are made in terms of constant U.S. dollars (2011). Growth is presented in terms of a compound average annual growth rate (CAGR). Prices are measured at the manufacturer level. Price levels of late 2011 to mid-2012 are used to determine market value, unless specified otherwise. Factors that influence price levels will be discussed.

INFORMATION SOURCES

Information sources for this report include experts, executives, professors, and officials in medical polymer companies; pharmaceutical companies; medical device manufacturing companies; industrial associations; universities; and governmental departments. These include Sinopec, China National Petroleum Corp. (CNPC), Hanwha Chemical Corp., Tsinghua University, the Ministry of Commerce of China, the China Chemical Fiber Association, and the National Bureau of Statistics of China. Information sources for the study also include online research, patent literature, technical journals, trade magazines, governmental data, and conference papers from various Chinese provinces and cities.

ANALYST CREDENTIALS

Jason Chen has been an analyst and consultant for the composite, fiber, textile, and energy industries for a decade. He has been a regular writer or contributing editor for Composites Manufacturing (American Composites Manufacturers Association), International Fiber Journal, Filtration News, Platts Emission Daily, Vision Systems Design, Pesticide and Toxic Chemical News, and MobileTex. He has authored the books “Asian Automotive Textiles: Opportunities and Challenges for Leading Producers,” “China Technical Textiles: Key Producers and Market Trends to 2015,” and “China’s Chemical Fiber Producers.” He is also the author of BCC market research report Tire Reinforcement Materials: Technologies and Global Markets (AVM077A).

Table Of Contents

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 3
SCOPE OF REPORT 3
INTENDED AUDIENCE 4
METHODOLOGY 4
INFORMATION SOURCES 4
ANALYST CREDENTIALS 4
RELATED BCC REPORTS 4
BCC ONLINE SERVICES 5
DISCLAIMER 5
CHAPTER 2 SUMMARY 7
SUMMARY TABLE MEDICAL POLYMER MARKET IN CHINA BY SEGMENT, THROUGH
2017 ($ MILLIONS) 7
SUMMARY FIGURE MEDICAL POLYMER MARKET IN CHINA BY SEGMENT, 2011-2017
($ MILLIONS) 7
LARGEST AND FASTEST-GROWING MARKETS 8
LARGEST MEDICAL POLYMER MARKETS 8
FASTEST-GROWING MEDICAL POLYMER MARKETS 8
SIGNIFICANT TRENDS 9
CHAPTER 3 OVERVIEW 12
DEFINITION OF THE INDUSTRY 12
FUTURE DEVELOPMENTS 12
TARGETS AND REGULATIONS 13
CARBON DIOXIDE EMISSION REDUCTION 13
CHINA'S 12TH FIVE YEAR PLAN FOR THE MEDICAL AND POLYMER
INDUSTRY 13
CHINESE NATIONAL STANDARD FOR MEDICAL POLYMERS 14
CHAPTER 4 CHINESE MEDICAL POLYMER MARKET BY PRODUCT 16
TABLE 1 CHINESE MARKET FOR MEDICAL POLYMERS BY PRODUCT, THROUGH 2017
($ MILLIONS) 17
CHINESE MARKET FOR MEDICAL RESINS AND FIBERS 17
TABLE 2 CHINESE MARKET FOR MEDICAL RESINS AND FIBERS BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 18
CHINESE MARKET FOR MEDICAL POLYETHYLENE (PE) 19
TABLE 3 CHINESE MARKET FOR MEDICAL POLYETHYLENE (PE) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 19
Current Status and History 21
Growth Drivers and Inhibitors 22
Growth Drivers 22
Growth Inhibitors 22
Trends and Opportunities 23
CHINESE MARKET FOR MEDICAL POLYVINYL CHLORIDE (PVC) 23
TABLE 4 CHINESE MARKET FOR MEDICAL POLYVINYL CHLORIDE (PVC) BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 24
Current Status and History 24
Growth Drivers and Inhibitors 25
Growth Drivers 25
Growth Inhibitors 25
Trends and Opportunities 26
CHINESE MARKET FOR MEDICAL POLYSTYRENE 26
TABLE 5 CHINESE MARKET FOR MEDICAL POLYSTYRENE (PS) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 27
Current Status and History 27
Growth Drivers and Inhibitors 28
Growth Drivers 28
Growth Inhibitors 28
Trends and Opportunities 29
CHINESE MARKET FOR MEDICAL POLYPROPYLENE (PP) 29
TABLE 6 CHINESE MARKET FOR MEDICAL POLYPROPYLENE (PP) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 29
Current Status and History 30
Growth Drivers and Inhibitors 30
Growth Drivers 30
Growth Inhibitors 31
Trends and Opportunities 31
CHINESE MARKET FOR MEDICAL POLYETHYLENE TEREPHTHALATE (PET) 31
TABLE 7 CHINESE MARKET FOR MEDICAL POLYETHYLENE TEREPHTHALATE (PET)
BY SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 32
Current Status and History 32
Growth Drivers and Inhibitors 33
Growth Drivers 33
Growth Inhibitors 33
Trends and Opportunities 34
CHINESE MARKET FOR MEDICAL ACRYLONITRILE BUTADIENE STYRENE
(ABS) 34
Current Status and History 34
TABLE 8 CHINESE MARKET FOR MEDICAL ACRYLONITRILE BUTADIENE STYRENE
(ABS) BY SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 35
Growth Drivers and Inhibitors 35
Growth Drivers 36
Growth Inhibitors 36
Trends and Opportunities 36
CHINESE MARKET FOR MEDICAL POLYAMIDE (PA) 36
TABLE 9 CHINESE MARKET FOR MEDICAL POLYAMIDE (PA) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 37
Current Status and History 37
Growth Drivers and Inhibitors 38
Growth Drivers 38
Growth Inhibitors 38
Trends and Opportunities 38
CHINESE MARKET FOR MEDICAL POLY METHYL METHACRYLATE (PMMA) 39
Current Status and History 39
Growth Drivers and Inhibitors 39
Growth Drivers 39
Growth Inhibitors 39
Trends and Opportunities 40
CHINESE MARKET FOR MEDICAL ELASTOMERS 40
TABLE 10 CHINESE MARKET FOR MEDICAL ELASTOMERS BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 40
CHINESE MARKET FOR MEDICAL POLYURETHANE (PU) 41
TABLE 11 CHINESE MARKET FOR MEDICAL POLYURETHANE (PU) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 41
Current Status and History 42
Growth Drivers and Inhibitors 42
Growth Drivers 42
Growth Inhibitors 42
Trends and Opportunities 43
CHINESE MARKET FOR MEDICAL SILICONE RUBBER 43
TABLE 12 CHINESE MARKET FOR MEDICAL SILICONE RUBBER BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 43
Current Status and History 44
Growth Drivers and Inhibitors 45
Growth Drivers 45
Growth Inhibitors 45
Trends and Opportunities 45
CHINESE MARKET FOR MEDICAL NATURAL RUBBER LATEX/ LOW-PROTEIN
NATURAL RUBBER LATEX (NRL/LPNRL) 45
TABLE 13 CHINESE MARKET FOR MEDICAL NATURAL RUBBER LATEX/
LOW-PROTEIN NATURAL RUBBER LATEX (NRL/LPNRL) BY SUBPRODUCT, THROUGH
2017 ($ MILLIONS)
46
Current Status and History 46
Growth Drivers and Inhibitors 47
Growth Drivers 47
Growth Inhibitors 47
Trends and Opportunities 47
CHINESE MARKET FOR MEDICAL BIODEGRADABLE POLYMERS 48
TABLE 14 CHINESE MARKET FOR MEDICAL BIODEGRADABLE POLYMERS BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 48
CHINESE MARKET FOR MEDICAL POLYLACTIC ACID (PLA) 49
TABLE 15 CHINESE MARKET FOR MEDICAL POLYLACTIC ACID (PLA) BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 49
Current Status and History 50
Growth Drivers and Inhibitors 50
Growth Drivers 50
Growth Inhibitors 51
Trends and Opportunities 51
CHINESE MARKET FOR MEDICAL POLYCARBONATE (PC) 51
TABLE 16 CHINESE MARKET FOR MEDICAL POLYCARBONATE (PC) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 52
Current Status and History 52
Growth Drivers and Inhibitors 52
Growth Drivers 53
Growth Inhibitors 53
Trends and Opportunities 53
CHINESE MARKET FOR MEDICAL POLYCAPROLACTONE (PCL) 53
Current Status and History 53
Growth Drivers and Inhibitors 54
Growth Drivers 54
Growth Inhibitors 54
Trends and Opportunities 54
CHAPTER 5 CHINESE MEDICAL POLYMER MARKET BY APPLICATION 56
TABLE 17 CHINESE MARKET FOR MEDICAL POLYMERS BY APPLICATION, THROUGH
2017 ($ MILLIONS) 56
MEDICAL EQUIPMENT 56
TABLE 18 CHINESE MARKET FOR MEDICAL EQUIPMENT POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 57
DISPOSABLE MEDICAL EQUIPMENT 57
HIGH-TECH MEDICAL EQUIPMENT 58
MEDICAL PACKAGING 58
TABLE 19 CHINESE MARKET FOR MEDICAL PACKAGING POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 59
MEDICINE PACKAGING 59
PACKAGING MATERIALS FOR MEDICAL APPARATUS 59
MEDICINE POLYMERS 59
TABLE 20 CHINESE MARKET FOR MEDICINE POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 60
MEDICINE ASSISTANT MATERIALS 60
POLYMER MEDICINES 60
PLASTIC SURGERY 61
TABLE 21 CHINESE MARKET FOR PLASTIC SURGERY POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 61
COSMETIC SURGERY 61
NON-COSMETIC PLASTIC SURGERY 62
ORTHOPEDICS 62
TABLE 22 CHINESE MARKET FOR ORTHOPEDIC POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 62
SKELETAL TRAUMA 62
OTHER 62
MEDICAL ADHESIVES AND SUTURES 63
TABLE 23 CHINESE MARKET FOR MEDICAL ADHESIVE AND SUTURE POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 63
MEDICAL ADHESIVE POLYMERS 63
NONDEGRADABLE SUTURE POLYMERS 64
DEGRADABLE SUTURE POLYMERS 64
OPHTHALMOLOGY 64
TABLE 24 CHINESE MARKET FOR OPHTHALMOLOGY POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 65
CONTACT LENSES AND INTRAOCULAR LENSES (IOLS) 65
OTHER 65
CARDIOVASCULAR SYSTEM 65
TABLE 25 CHINESE MARKET FOR CARDIOVASCULAR POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 66
ARTIFICIAL HEART 66
ARTIFICIAL BLOOD VESSELS 66
ARTIFICIAL LUNGS 67
CHAPTER 6 CHINESE MEDICAL POLYMER MARKET BY REGION 69
TABLE 26 CHINESE MEDICAL POLYMER MARKET BY REGION, THROUGH 2017 ($
MILLIONS) 70
YANGTZE RIVER DELTA REGION 70
TABLE 27 YANGTZE RIVER DELTA MEDICAL POLYMER MARKET BY PROVINCE/CITY,
THROUGH 2017 ($ MILLIONS) 71
JIANGSU PROVINCE 71
TABLE 28 JIANGSU MEDICAL POLYMER MARKET BY CITY, THROUGH 2017 ($
MILLIONS) 72
Suzhou 72
Important Suppliers 72
Important Consumers 73
Nanjing 73
Important Suppliers 73
Important Consumers 73
Changzhou 74
Important Suppliers 74
Important Consumers 74
Wuxi 74
Important Suppliers 75
Important Consumers 75
Zhenjiang 75
Important Suppliers 75
Important Consumers 76
Yangzhou 76
Important Suppliers 76
Important Consumers 76
Nantong 77
Important Suppliers 77
Important Consumers 77
Taizhou, Jiangsu 77
Important Suppliers 78
Important Consumers 78
Lianyungang 78
Important Suppliers 78
Important Consumers 78
ZHEJIANG PROVINCE 79
TABLE 29 ZHEJIANG MEDICAL POLYMER MARKET BY CITY, THROUGH 2017 ($
MILLIONS) 79
Hangzhou 79
Important Suppliers 80
Important Consumers 80
Ningbo 80
Important Suppliers 80
Important Consumers 81
Shaoxing 81
Important Suppliers 81
Important Consumers 81
Taizhou, Zhejiang 82
Important Suppliers 82
Important Consumers 82
Jiaxing 82
Important Suppliers 83
Important Consumers 83
Huzhou 83
Important Suppliers 83
Important Consumers 83
Jinhua 84
Important Suppliers 84
Important Consumers 84
Shanghai 84
Important Suppliers 85
Important Consumers 86
GROWTH DRIVERS AND INHIBITORS OF YANGTZE RIVER DELTA REGION 86
Growth Drivers 87
Growth Inhibitors 87
TRENDS 87
THE PEARL RIVER DELTA REGION 88
TABLE 30 PEARL RIVER DELTA MEDICAL POLYMER MARKET BY CITY, THROUGH
2017 ($ MILLIONS) 88
PEARL RIVER DELTA MEDICAL POLYMER MARKET AND INDUSTRY BY CITY 89
Guangzhou 89
Important Suppliers 89
Important Consumers 89
Shenzhen 90
Important Suppliers 90
Important Consumers 90
Foshan 90
Important Suppliers 91
Important Consumers 91
Dongguan 91
Important Suppliers 91
Important Consumers 92
Zhuhai 92
Important Suppliers 92
Important Consumers 92
Zhongshan 93
Important Suppliers 93
Important Consumers 93
Huizhou 93
Important Suppliers 93
Important Consumers 94
Zhanjiang 94
Important Suppliers 94
Important Consumers 94
GROWTH DRIVERS AND INHIBITORS 94
Growth Drivers 95
Growth Inhibitors 95
TRENDS 95
NORTH CHINA REGION 96
TABLE 31 NORTH CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY,
THROUGH 2017 ($ MILLIONS) 96
NORTH CHINA MEDICAL POLYMER MARKET AND INDUSTRY BY
PROVINCE/CITY 96
Beijing 96
Important Suppliers 97
Important Consumers 97
Tianjin 97
Important Suppliers 97
Important Consumers 98
Hebei 98
Important Suppliers 98
Important Consumers 98
Shanxi 99
Important Suppliers 99
Important Consumers 99
Inner Mongolia 99
Important Suppliers 99
Important Consumers 100
GROWTH DRIVERS AND INHIBITORS 100
Growth Drivers 100
Growth Inhibitors 100
TRENDS 101
MIDDLE CHINA REGION 101
TABLE 32 MIDDLE CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY,
THROUGH 2017 ($ MILLIONS) 101
MIDDLE CHINA MEDICAL POLYMER MARKET AND INDUSTRY BY
PROVINCE/CITY 102
Henan 102
Important Suppliers 102
Important Consumers 102
Hubei 103
Important Suppliers 103
Important Consumers 103
Hunan 104
Important Suppliers 104
Important Consumers 104
GROWTH DRIVERS AND INHIBITORS 104
Growth Drivers 104
Growth Inhibitors 105
TRENDS 105
OTHER REGIONS 105
TABLE 33 OTHER MEDICAL POLYMER MARKET BY SEGMENT, THROUGH 2017 ($
MILLIONS) 106
EAST CHINA 106
TABLE 34 EAST CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY, THROUGH
2017 ($ MILLIONS) 106
Shandong 107
Important Suppliers 107
Important Consumers 107
Anhui 108
Important Suppliers 108
Important Consumers 108
Liaoning 108
Important Suppliers 108
Important Consumers 109
Fujian 109
Important Suppliers 109
Important Consumers 109
Jiangxi 110
Important Suppliers 110
Important Consumers 110
WEST CHINA 111
TABLE 35 WEST CHINA MEDICAL POLYMER MARKET BY CITY/PROVINCE, THROUGH
2017 ($ MILLIONS) 111
Sichuan 111
Important Suppliers 112
Important Consumers 112
Shaanxi 112
Important Suppliers 112
Important Consumers 113
Yunnan 113
Important Suppliers 113
Important Consumers 113
Chongqing 113
Important Suppliers 114
Important Consumers 114
Guangxi 114
Important Suppliers 114
Important Consumers 114
Gansu 115
Important Suppliers 115
Important Consumers 115
Xinjiang 115
Important Suppliers 115
Important Consumers 116
Ningxia 116
Important Suppliers 116
Important Consumers 116
GROWTH DRIVERS AND INHIBITORS 117
Growth Drivers 117
Growth Inhibitors 117
TRENDS 117
CHAPTER 7 TECHNOLOGIES 119
TECHNOLOGIES RELATED TO MEDICAL POLYETHYLENE (PE) 119
TECHNOLOGIES RELATED TO MEDICAL POLYVINYL CHLORIDE (PVC) 119
TECHNOLOGIES RELATED TO MEDICAL POLYPROPYLENE (PP) 120
TECHNOLOGIES RELATED TO MEDICAL ACRYLONITRILE BUTADIENE STYRENE
(ABS) 120
TECHNOLOGIES RELATED TO MEDICAL POLYETHYLENE TEREPHTHALATE (PET) 120
TECHNOLOGIES RELATED TO MEDICAL POLYURETHANE (PU) 120
TECHNOLOGIES RELATED TO MEDICAL SILICONE RUBBER 121
TECHNOLOGIES RELATED TO MEDICAL NATURAL RUBBER LATEX (NRL) AND
LOW-PROTEIN NATURAL RUBBER LATEX (LPNRL) 121
TECHNOLOGIES RELATED TO ULTRA HIGH MOLECULAR WEIGHT POLYETHYLENE
(UHMWPE) 122
SIGNIFICANT TECHNOLOGICAL DEVELOPMENTS 122
TABLE 36 SIGNIFICANT DEVELOPMENTS IN MANUFACTURING TECHNOLOGIES,
SINCE 2006 123
CHINESE PATENT ANALYSIS 124
PATENTS BY COMPANY 124
TABLE 37 CHINESE MEDICAL POLYMER PATENT NUMBERS BY COMPANY,
RESEARCH INSTITUTE, AND UNIVERSITY, 2007-2012 124
PATENTS BY YEAR 124
TABLE 38 CHINESE MEDICAL POLYMER PATENT NUMBERS BY YEAR, 2007-2012
(NUMBER OF PATENTS) 125
CHAPTER 8 INDUSTRY STRUCTURE AND COMPETITIVE ANALYSIS 127
MARKET PLAYERS 127
INDUSTRY LEADERS 127
STRATEGIES FOR STAYING COMPETITIVE AND SUCCESSFUL 128
RISK CONTROL 128
VALUE-ADDED PRODUCTS 128
HUMAN SAFETY 129
LOW LABOR COSTS 129
IMPORTANT SHIFTS 129
CHAPTER 9 COMPANY PROFILES 133
BASF-YPC CO. LTD. 133
BLUESTAR NEW CHEMICAL MATERIALS CO. LTD. 133
CHENGDU DIKANG ZHONGKE BIOMEDICAL MATERIALS CO. LTD. 134
CHINA HAOHUA CHEMICAL GROUP CO. LTD. 134
CHINA NATIONAL PETROLEUM CORP. (CNPC) 134
DOW CORNING (CHINA) HOLDING CO. LTD. 135
FORMOSA PLASTICS GROUP 136
GUANGDONG SANKAI NEW MATERIALS CO. LTD. 136
GUANGDONG SHENGHENGCHANG CHEMICAL INDUSTRY CO. LTD. 137
HUIZHOU FORYOU MEDICAL DEVICE CO. LTD. 137
JAFRON BIOMEDICAL CO. LTD. 138
LIANGSHAN SANLI RESIN CO. LTD. 138
NINGBO YONGHUA RESIN CO. LTD. 138
NORTH HUAJIN CHEMICAL INDUSTRIES GROUP CORP. 139
PANJIN ETHYLENE CO. LTD. 139
PETROCHINA DAQING PETROCHEMICAL CO. 139
PIAOAN GROUP 140
SHANGHAI CHLOR-ALKALI CHEMICAL CO. LTD. 140
SHANGHAI NEW SHANGHUA POLYMER MATERIAL CO. LTD. 141
SHANGHAI SECCO PETROCHEMICAL CO. LTD. 141
SHINETSU SHANGHAI CO. LTD. 142
SINOPEC BEIJING YANSHAN CO. 142
SINOPEC SHANGHAI PETROCHEMICAL CO. LTD. 143
TIANJIN PLASTICS RESEARCH INSTITUTE CO. LTD. 143
WEIGAO HOLDING CO. LTD. (WEGO) 143
YANGZHOU KAIER CHEMICAL CO. LTD. 144
ZHEJIANG XINAN CHEMICAL INDUSTRIAL GROUP CO. LTD. 144
ZHENJIANG CHI MEI CO. LTD. 145
CHAPTER 10 APPENDIX I: PATENTS 147
A MEDICAL PLASTIC PACKAGING MACHINE 147
A NON-PVC BLOOD EXTRACORPOREAL CIRCUIT 147
APPLICATION OF ALDEHYDE MODIFIED POLYSACCHARIDE WITH CARBOXYL IN
MAKING MEDICINES AND MEDICAL MATERIALS 147
DEVICE OF SIMULATING BIOLOGICAL MEDICAL MATERIAL IN VITRO DYNAMIC
CORROSION 147
METHOD OF MAKING A COLLAGEN-BASED BIOMATERIAL 148
METHOD OF MAKING BIOLOGICAL MEDICAL MATERIAL WITH BIOLOGICAL
RESPONSIVE COATING 148
METHOD OF MAKING COLLAGEN MATRIX FREEZING GEL FOR BIOLOGICAL
MEDICAL MATERIAL 148
METHOD OF MAKING ELECTROSTATIC SELF-ASSEMBLY MODIFIED NANO FIBER
BIOMEDICAL MATERIAL 148
METHOD OF MAKING NANO-HYDROXYAPATITE/SILICONE RUBBER COMPOSITE
BIOMATERIALS 149
METHOD OF MAKING TUSSAH SILK FIBROIN BIOMATERIALS 149
CHAPTER 11 APPENDIX II: REGULATIONS AND TARGETS 151
CHAPTER 12 APPENDIX III: GLOSSARY 153
CHAPTER 13 APPENDIX IV: BIBLIOGRAPHY 158

LIST OF TABLES
SUMMARY TABLE MEDICAL POLYMER MARKET IN CHINA BY SEGMENT, THROUGH
2017 ($ MILLIONS) 7
TABLE 1 CHINESE MARKET FOR MEDICAL POLYMERS BY PRODUCT, THROUGH 2017
($ MILLIONS) 17
TABLE 2 CHINESE MARKET FOR MEDICAL RESINS AND FIBERS BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 18
TABLE 3 CHINESE MARKET FOR MEDICAL POLYETHYLENE (PE) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 19
TABLE 4 CHINESE MARKET FOR MEDICAL POLYVINYL CHLORIDE (PVC) BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 24
TABLE 5 CHINESE MARKET FOR MEDICAL POLYSTYRENE (PS) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 27
TABLE 6 CHINESE MARKET FOR MEDICAL POLYPROPYLENE (PP) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 29
TABLE 7 CHINESE MARKET FOR MEDICAL POLYETHYLENE TEREPHTHALATE (PET) BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 32
TABLE 8 CHINESE MARKET FOR MEDICAL ACRYLONITRILE BUTADIENE STYRENE (ABS)
BY SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 35
TABLE 9 CHINESE MARKET FOR MEDICAL POLYAMIDE (PA) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 37
TABLE 10 CHINESE MARKET FOR MEDICAL ELASTOMERS BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 40
TABLE 11 CHINESE MARKET FOR MEDICAL POLYURETHANE (PU) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 41
TABLE 12 CHINESE MARKET FOR MEDICAL SILICONE RUBBER BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 43
TABLE 13 CHINESE MARKET FOR MEDICAL NATURAL RUBBER LATEX/ LOW-PROTEIN
NATURAL RUBBER LATEX (NRL/LPNRL) BY SUBPRODUCT, THROUGH 2017 ($
MILLIONS)
46
TABLE 14 CHINESE MARKET FOR MEDICAL BIODEGRADABLE POLYMERS BY
SUBPRODUCT, THROUGH 2017 ($ MILLIONS) 48
TABLE 15 CHINESE MARKET FOR MEDICAL POLYLACTIC ACID (PLA) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 49
TABLE 16 CHINESE MARKET FOR MEDICAL POLYCARBONATE (PC) BY SUBPRODUCT,
THROUGH 2017 ($ MILLIONS) 52
TABLE 17 CHINESE MARKET FOR MEDICAL POLYMERS BY APPLICATION, THROUGH
2017 ($ MILLIONS) 56
TABLE 18 CHINESE MARKET FOR MEDICAL EQUIPMENT POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 57
TABLE 19 CHINESE MARKET FOR MEDICAL PACKAGING POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 59
TABLE 20 CHINESE MARKET FOR MEDICINE POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 60
TABLE 21 CHINESE MARKET FOR PLASTIC SURGERY POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 61
TABLE 22 CHINESE MARKET FOR ORTHOPEDIC POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 62
TABLE 23 CHINESE MARKET FOR MEDICAL ADHESIVE AND SUTURE POLYMERS BY
SUBAPPLICATION, THROUGH 2017 ($ MILLIONS) 63
TABLE 24 CHINESE MARKET FOR OPHTHALMOLOGY POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 65
TABLE 25 CHINESE MARKET FOR CARDIOVASCULAR POLYMERS BY SUBAPPLICATION,
THROUGH 2017 ($ MILLIONS) 66
TABLE 26 CHINESE MEDICAL POLYMER MARKET BY REGION, THROUGH 2017 ($
MILLIONS) 70
TABLE 27 YANGTZE RIVER DELTA MEDICAL POLYMER MARKET BY PROVINCE/CITY,
THROUGH 2017 ($ MILLIONS) 71
TABLE 28 JIANGSU MEDICAL POLYMER MARKET BY CITY, THROUGH 2017 ($
MILLIONS) 72
TABLE 29 ZHEJIANG MEDICAL POLYMER MARKET BY CITY, THROUGH 2017 ($
MILLIONS) 79
TABLE 30 PEARL RIVER DELTA MEDICAL POLYMER MARKET BY CITY, THROUGH 2017
($ MILLIONS) 88
TABLE 31 NORTH CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY, THROUGH
2017 ($ MILLIONS) 96
TABLE 32 MIDDLE CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY, THROUGH
2017 ($ MILLIONS) 101
TABLE 33 OTHER MEDICAL POLYMER MARKET BY SEGMENT, THROUGH 2017 ($
MILLIONS) 106
TABLE 34 EAST CHINA MEDICAL POLYMER MARKET BY PROVINCE/CITY, THROUGH
2017 ($ MILLIONS) 106
TABLE 35 WEST CHINA MEDICAL POLYMER MARKET BY CITY/PROVINCE, THROUGH
2017 ($ MILLIONS) 111
TABLE 36 SIGNIFICANT DEVELOPMENTS IN MANUFACTURING TECHNOLOGIES, SINCE
2006 123
TABLE 37 CHINESE MEDICAL POLYMER PATENT NUMBERS BY COMPANY, RESEARCH
INSTITUTE, AND UNIVERSITY, 2007-2012 124
TABLE 38 CHINESE MEDICAL POLYMER PATENT NUMBERS BY YEAR, 2007-2012
(NUMBER OF PATENTS) 125

LIST OF FIGURES
SUMMARY FIGURE MEDICAL POLYMER MARKET IN CHINA BY SEGMENT, 2011-2017
($ MILLIONS) 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Specialty Fibers: Technologies and Global Markets

Specialty Fibers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report covers the underlying economic issues driving the specialty fiber and materials business as well as assessments of new and potential products that companies are developing. It ...

Carbon Fibers Technology - 9 Dimensional Assessment (Technical Insights)

Carbon Fibers Technology - 9 Dimensional Assessment (Technical Insights)

  • $ 6 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

Evaluating Carbon Fibers through a 9'Dimensional Approach This research service evaluates carbon fibers across nine different matrices including IP Intensity, Market Potential, Funding Scenario, Global ...

Technology Convergence Scenrios (Technical Insights)

Technology Convergence Scenrios (Technical Insights)

  • $ 6 500
  • Industry report
  • September 2014
  • by Frost & Sullivan

Technology Convergence 5 Convergence Scenario Examples using the top 50 technologies generated by Technical Insights in 2014 Promoting Self repairing through Self Healing Materials Increasing focus on ...

World Specialty Silicas Market

August 2014 $ 6 300

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.